Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-04

Clinical Trial Update: Fractionated Carbon Dioxide Laser Therapy for Treatment of Peyronie's Disease [NA]

View source ↗

Summary

The University of British Columbia-sponsored trial evaluating fractionated carbon dioxide laser therapy for Peyronie's disease has completed (Status: COMPLETED)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of British Columbia | Conditions: Peyronies Disease | NA | Status: COMPLETED